Matteo Caracciolo

7PUBLICATIONS
26CO-AUTHORS
Pharmaceutical delivery technologiesTe ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)Veterinary diagnosis and diagnosticsPharmacogenomicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 26, 2024
Prognostic Role of PSMA-Targeted Imaging in Metastatic Castration-Resistant Prostate Cancer: An Overview.

Matteo Caracciolo, Angelo Castello, Massimo Castellani

|Aug 26, 2023
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives.

Matteo Caracciolo, Angelo Castello, Luca Urso

|Mar 29, 2023
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score.

Francesco Dondi, Achille Lazzarato, Joana Gorica

|Feb 25, 2023
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT.

Luca Urso, Angelo Castello, Giorgio Treglia

|Oct 27, 2022
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial.

Luca Urso, Stefano Panareo, Angelo Castello

|Oct 27, 2022
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review.

Matteo Caracciolo, Angelo Castello, Luca Urso

Pageof 2

Frequent Collaborators

6 joint publications

Luca Urso

5 joint publications

Licia Uccelli

5 joint publications

Corrado Cittanti

4 joint publications

Massimo Castellani